Chris Hamby
@ChrisDHamby
Followers
6K
Following
213
Media
131
Statuses
3K
Investigative reporter @NYTimes. Author of Soul Full of Coal Dust, in stores and online now: https://t.co/BQffThH14M. D.C. resident. Nashville native.
Joined September 2010
To understand the at-home ketamine boom, I spoke with 40+ patients. Many called the drug profoundly helpful, but some described addiction and bladder problems -- known risks of recreational use that have been largely downplayed in the medical community. https://t.co/E4Nfr1NAZ7
nytimes.com
With loosened rules around remote prescriptions, a psychedelic-like drug has become a popular treatment for mental health conditions. But a boom in at-home use has outpaced evidence of safety.
5
8
24
Pandemic-era telemedicine rule changes have made it much easier to take the mind-altering drug ketamine at home. Many mental health patients have benefited, but the industry's rapid growth has outpaced evidence of safety.
nytimes.com
With loosened rules around remote prescriptions, a psychedelic-like drug has become a popular treatment for mental health conditions. But a boom in at-home use has outpaced evidence of safety.
1
2
4
Primed by glowing media coverage and aggressive advertising, many patients regard ketamine and its newfound at-home availability as akin to a miracle cure. But there are many unknowns -- and risks. An investigation by @ChrisDHamby @nytimes
nytimes.com
With loosened rules around remote prescriptions, a psychedelic-like drug has become a popular treatment for mental health conditions. But a boom in at-home use has outpaced evidence of safety.
3
8
8
These workers are slowly suffocating to death after fabricating engineered-stone countertops: https://t.co/2f7BVlo1ZN Great work by @JimGMorris @Multi_American @pubhealthwatch
publichealthwatch.org
Since January 2016, at least 30 artificial-stone fabricators in the Los Angeles area have been diagnosed with an accelerated form of silicosis, a deadly, dust-related illness.
0
5
10
Congratulations to @JimGMorris and the crew @pubhealthwatch on a year of great investigative journalism:
publichealthwatch.org
Public Health Watch turns a year old on Wednesday. That’s hard for me to fathom. A year goes by very quickly when you’re engrossed in something meaningful. A little history is in order.
0
4
8
Peruse for yourself the 100,00-plus documents that @PekingMike & I used to tell the story of McKinsey's broader work for opioid manufacturers: https://t.co/WTe9KTOA25 Our story:
nytimes.com
The consulting firm offered clients “in-depth experience in narcotics,” from poppy fields to pills more powerful than Purdue’s OxyContin.
2
4
13
In addition to helping Purdue Pharma "turbocharge" OxyContin sales while overdoses were surging in America, consulting giant McKinsey simultaneously worked with other drugmakers to boost $$$ of even stronger opioids like Opana. @ChrisDHamby @PekingMike
https://t.co/ySNJRFMEaw
nytimes.com
The consulting firm offered clients “in-depth experience in narcotics,” from poppy fields to pills more powerful than Purdue’s OxyContin.
2
12
14
McKinsey's work for opioid makers went well beyond Purdue, a vast new trove of documents shows. The firm counseled companies at the core of the crisis. w/@PekingMike
nytimes.com
The consulting firm offered clients “in-depth experience in narcotics,” from poppy fields to pills more powerful than Purdue’s OxyContin.
7
36
42
EXCLUSIVE: As part of its 2021 settlement with US states, McKinsey pledged to make public documents on its work with opioid makers going back more than a decade. The docs show the firm's advice extended well beyond Purdue Pharma. By @ChrisDHamby and me
nytimes.com
The consulting firm offered clients “in-depth experience in narcotics,” from poppy fields to pills more powerful than Purdue’s OxyContin.
10
40
86
Amid withering questioning from members of Congress, McKinsey's top executive maintained that simultaneously serving both Purdue Pharma and its chief regulator, the F.D.A., was not a conflict of interest.
nytimes.com
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
3
26
42
In a hearing today, McKinsey's top executive apologized for the firm's work for opioid manufacturers. Members of Congress called his words hollow and referred to the $86 million McKinsey received from Purdue Pharma as "blood money." w/@PekingMike @waltbogdanich
1
9
18
Op-ed from a retired miner with black lung: Benefits in jeopardy w/out action by Congress. "I am absolutely counting on Manchin to get this done." https://t.co/6UqhARkz7z I had the privilege of speaking with Arvin for my book. His predicament hasn't dampened his jovial optimism.
wvgazettemail.com
It didn’t happen overnight, but little by little, I could feel it getting harder to breathe.
0
2
1
Have a look at some of the documents we drew on to tell the story of McKinsey and its work for both opioid manufacturers and the F.D.A.: https://t.co/CqSyiTh128
https://t.co/v0RKg2x52s
0
2
4
Newly released documents show: McKinsey consultants worked for both Purdue Pharma and its regulator, the F.D.A. The firm stressed its govt. connections when pitching pharma cos. -- "who we know and what we know." w/@waltbogdanich @PekingMike @jenvalentino
nytimes.com
The firm let consultants advise both drugmakers and their government overseers, internal records show. “Who we know and what we know” was part of their pitch.
3
11
17
Overlooked No More: Elizabeth Hayes, the coal town doctor who fought for miners' health: https://t.co/jN7hwbM4k0 Appreciation to @greenhousenyt for telling the story.
nytimes.com
“Dr. Betty” led 350 miners on a strike in Pennsylvania in 1945 demanding that the mining company that owned their town improve horridly unsanitary conditions.
0
2
4
For anyone looking for a good read on a timely subject, might I suggest my former @publicintegrity colleague Ronnie Greene's new book Heart of Atlanta: https://t.co/j65lqINpNe It's the human story behind one of the most underappreciated Supreme Court civil rights cases.
0
2
0
Nice @niemanstory interview with @JimGMorris -- fellow @publicintegrity alumnus, legendary reporter and beard aficionado -- about launching a nonprofit investigative news outlet (@pubhealthwatch) during a pandemic:
0
2
0
“It was pretty clear that we failed.” @ChrisDHamby and @SherylNYT reveal the backstory to the Covid vaccine production failures in Baltimore. A surprising cast of culprits. @nytimes
nytimes.com
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
2
6
9
The Covid-19 vaccine manufacturing failures at Emergent BioSolutions this year were the culmination of 30 years of frustrations. Our investigation dug into the forgotten history that led here. https://t.co/6QXzfMUb6b w/@SherylNYT
nytimes.com
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
0
2
2
Emergent BioSolutions was meant to be a pillar of the U.S.’s pandemic plan. Here’s the forgotten history that led to a searing failure.
nytimes.com
Washington has rejected plans to revamp vaccine preparedness for decades and repeatedly paid a price. The Biden administration is at a similar crossroads.
11
14
65